A nurse has completed teaching a client who is being discharged on lithium for a bipolar disorder

1. Berk M, Berk L, Castle D. A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disord. 2004;6:504–518. [PubMed] [Google Scholar]

2. Berk L, Hallam KT, Colom F, Vieta E, Hasty M, Macneil C, Berk M. Enhancing medication adherence in patients with bipolar disorder. Hum Psychopharmacol. 2010;25:1–16. [PubMed] [Google Scholar]

3. Guscott R, Taylor L. Lithium prophylaxis in recurrent affective illness. Efficacy, effectiveness and efficiency. Br J Psychiatry. 1994;164:741–746. [PubMed] [Google Scholar]

4. Colom F, Vieta E, Tacchi MJ, Sánchez-Moreno J, Scott J. Identifying and improving non-adherence in bipolar disorders. Bipolar Disord. 2005;7 Suppl 5:24–31. [PubMed] [Google Scholar]

5. Gianfrancesco FD, Sajatovic M, Rajagopalan K, Wang RH. Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder. Clin Ther. 2008;30:1358–1374. [PubMed] [Google Scholar]

6. Rascati KL, Richards KM, Ott CA, Goddard AW, Stafkey-Mailey D, Alvir J, Sanders KN, Mychaskiw M. Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder. Psychiatr Serv. 2011;62:1032–1040. [PubMed] [Google Scholar]

7. Johnson FR, Ozdemir S, Manjunath R, Hauber AB, Burch SP, Thompson TR. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach. Med Care. 2007;45:545–552. [PubMed] [Google Scholar]

8. Rakofsky JJ, Levy ST, Dunlop BW. Conceptualizing Treatment Nonadherence in Patients with Bipolar Disorder and PTSD. CNS Spectr. 2011;16:11–20. [PubMed] [Google Scholar]

9. Sabate E. Adherence to long term therapies: evidence for action. Geneva: World Health Organization; 2003. [Google Scholar]

10. McCleod MS, Sharp DM. Precursors of compliance with lithium treatment in affective disorders. Psychiatr Bull. 2001;25:183–186. [Google Scholar]

11. Clatworthy J, Bowskill R, Rank T, Parham R, Horne R. Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients’ beliefs about the condition and its treatment. Bipolar Disord. 2007;9:656–664. [PubMed] [Google Scholar]

12. Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Calabrese JR, Bowden CL, Ketter TA, Friedman ES, Iosifescu DV, Thase ME, et al. Medication adherence in a comparative effectiveness trial for bipolar disorder. Acta Psychiatr Scand. 2014;129:359–365. [PMC free article] [PubMed] [Google Scholar]

13. Crowe M, Wilson L, Inder M. Patients’ reports of the factors influencing medication adherence in bipolar disorder - an integrative review of the literature. Int J Nurs Stud. 2011;48:894–903. [PubMed] [Google Scholar]

14. Gaudiano BA, Weinstock LM, Miller IW. Improving treatment adherence in bipolar disorder: a review of current psychosocial treatment efficacy and recommendations for future treatment development. Behav Modif. 2008;32:267–301. [PMC free article] [PubMed] [Google Scholar]

15. Jónsdóttir H, Opjordsmoen S, Birkenaes AB, Engh JA, Ringen PA, Vaskinn A, Aamo TO, Friis S, Andreassen OA. Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level. J Clin Psychopharmacol. 2010;30:169–175. [PubMed] [Google Scholar]

16. Jónsdóttir H, Opjordsmoen S, Birkenaes AB, Simonsen C, Engh JA, Ringen PA, Vaskinn A, Friis S, Sundet K, Andreassen OA. Predictors of medication adherence in patients with schizophrenia and bipolar disorder. Acta Psychiatr Scand. 2013;127:23–33. [PubMed] [Google Scholar]

17. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry. 2002;63:384–390. [PubMed] [Google Scholar]

18. Sajatovic M, Davies M, Bauer MS, McBride L, Hays RW, Safavi R, Jenkins J. Attitudes regarding the collaborative practice model and treatment adherence among individuals with bipolar disorder. Compr Psychiatry. 2005;46:272–277. [PubMed] [Google Scholar]

19. Rosa AR, Marco M, Fachel JM, Kapczinski F, Stein AT, Barros HM. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:217–224. [PubMed] [Google Scholar]

20. Manwani SG, Szilagyi KA, Zablotsky B, Hennen J, Griffin ML, Weiss RD. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. J Clin Psychiatry. 2007;68:1172–1176. [PubMed] [Google Scholar]

21. Keck PE, McElroy SL, Strakowski SM, Stanton SP, Kizer DL, Balistreri TM, Bennett JA, Tugrul KC, West SA. Factors associated with pharmacologic noncompliance in patients with mania. J Clin Psychiatry. 1996;57:292–297. [PubMed] [Google Scholar]

22. Miasso AI, do Carmo BP, Tirapelli CR. Bipolar affective disorder: pharmacotherapeutic profile and adherence to medication. Rev Esc Enferm USP. 2012;46:689–695. [PubMed] [Google Scholar]

23. Montes JM, Maurino J, de Dios C, Medina E. Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning. Patient Prefer Adherence. 2013;7:89–94. [PMC free article] [PubMed] [Google Scholar]

24. Cochran SD. Compliance with lithium regimens in the outpatient treatment of bipolar affective disorders. J Compliance Health Care. 1986;1:153–170. [Google Scholar]

25. Goodwin F, Jamison JK. Manic depressive illness. New York: Oxford University Press; 1990. [Google Scholar]

26. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002;105:164–172. [PubMed] [Google Scholar]

27. Perlick DA, Rosenheck RA, Kaczynski R, Kozma L. Medication non-adherence in bipolar disorder: a patient-centered review of research findings. Clin Approaches Bipolar Disord. 2004;3:56–64. [Google Scholar]

28. Leclerc E, Mansur RB, Brietzke E. Determinants of adherence to treatment in bipolar disorder: a comprehensive review. J Affect Disord. 2013;149:247–252. [PubMed] [Google Scholar]

29. Schou M. The combat of non-compliance during prophylactic lithium treatment. Acta Psychiatr Scand. 1997;95:361–363. [PubMed] [Google Scholar]

30. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 1998;49:196–201. [PubMed] [Google Scholar]

31. DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–209. [PubMed] [Google Scholar]

32. Chakrabarti S. What’s in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World J Psychiatry. 2014;4:30–36. [PMC free article] [PubMed] [Google Scholar]

33. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. The rational clinical examination. Is this patient taking the treatment as prescribed? JAMA. 1993;269:2779–2781. [PubMed] [Google Scholar]

34. Aagaard J, Vestergaard P. Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J Affect Disord. 1990;18:259–266. [PubMed] [Google Scholar]

35. Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol. 2008;23:95–105. [PubMed] [Google Scholar]

36. Vieta E, Azorin JM, Bauer M, Frangou S, Perugi G, Martinez G, Schreiner A. Psychiatrists’ perceptions of potential reasons for non- and partial adherence to medication: results of a survey in bipolar disorder from eight European countries. J Affect Disord. 2012;143:125–130. [PubMed] [Google Scholar]

37. Jamison KR, Gerner RH, Goodwin FK. Patient and physician attitudes toward lithium: relationship to compliance. Arch Gen Psychiatry. 1979;36:866–869. [PubMed] [Google Scholar]

38. Busby KK, Sajatovic M. REVIEW: Patient, treatment, and systems-level factors in bipolar disorder nonadherence: A summary of the literature. CNS Neurosci Ther. 2010;16:308–315. [PMC free article] [PubMed] [Google Scholar]

39. Depp CA, Moore DJ, Patterson TL, Lebowitz BD, Jeste DV. Psychosocial interventions and medication adherence in bipolar disorder. Dialogues Clin Neurosci. 2008;10:239–250. [PMC free article] [PubMed] [Google Scholar]

40. Scott J. Cognitive and behavioural approaches to medication adherence. Adv Psychiatr Treat. 1999;5:338–345. [Google Scholar]

41. Clatworthy J, Bowskill R, Parham R, Rank T, Scott J, Horne R. Understanding medication non-adherence in bipolar disorders using a Necessity-Concerns Framework. J Affect Disord. 2009;116:51–55. [PubMed] [Google Scholar]

42. Basco MR, Smith J. Faulty decision-making: impact on treatment adherence in bipolar disorder. Primary Psychiatry. 2009:16: 53–58. [Google Scholar]

43. Mączka G, Siwek M, Skalski M, Grabski B, Dudek D. Patients’ and doctors’ attitudes towards bipolar disorder – do we share our beliefs? Archives of Psychiatry and Psychotherapy. 2010;2:43–50. [Google Scholar]

44. Johnson SL, Fulford D. Development of the treatment attitudes questionnaire in bipolar disorder. J Clin Psychol. 2008;64:466–481. [PMC free article] [PubMed] [Google Scholar]

45. Scott J. Using Health Belief Models to understand the efficacy-effectiveness gap for mood stabilizer treatments. Neuropsychobiology. 2002;46 Suppl 1:13–15. [PubMed] [Google Scholar]

46. Arvilommi P, Suominen K, Mantere O, Leppämäki S, Valtonen H, Isometsä E. Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders - an 18-month prospective study. J Affect Disord. 2014;155:110–117. [PubMed] [Google Scholar]

47. Colom F, Vieta E, Martínez-Arán A, Reinares M, Benabarre A, Gastó C. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry. 2000;61:549–555. [PubMed] [Google Scholar]

48. Sajatovic M, Bauer MS, Kilbourne AM, Vertrees JE, Williford W. Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatr Serv. 2006;57:56–62. [PubMed] [Google Scholar]

49. Sajatovic M, Biswas K, Kilbourne AK, Fenn H, Williford W, Bauer MS. Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder. Psychiatr Serv. 2008;59:753–759. [PubMed] [Google Scholar]

50. Sajatovic M, Ignacio RV, West JA, Cassidy KA, Safavi R, Kilbourne AM, Blow FC. Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr Psychiatry. 2009;50:100–107. [PMC free article] [PubMed] [Google Scholar]

51. Schumann C, Lenz G, Berghöfer A, Müller-Oerlinghausen B. Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Res. 1999;89:247–257. [PubMed] [Google Scholar]

52. Frank E, Prien RF, Kupfer DJ, Alberts L. Implications of noncompliance on research in affective disorders. Psychopharmacol Bull. 1985;21:37–42. [PubMed] [Google Scholar]

53. Jamison KR, Akiskal HS. Medication compliance in patients with bipolar disorder. Psychiatr Clin North Am. 1983;6:175–192. [PubMed] [Google Scholar]

54. Keck PE, McElroy SL, Strakowski SM, Bourne ML, West SA. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull. 1997;33:87–91. [PubMed] [Google Scholar]

55. Strakowski SM, Keck PE, McElroy SL, West SA, Sax KW, Hawkins JM, Kmetz GF, Upadhyaya VH, Tugrul KC, Bourne ML. Twelve-month outcome after a first hospitalization for affective psychosis. Arch Gen Psychiatry. 1998;55:49–55. [PubMed] [Google Scholar]

56. Sajatovic M, Valenstein M, Blow F, Ganoczy D, Ignacio R. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv. 2007;58:855–863. [PubMed] [Google Scholar]

57. Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord. 2006;8:232–241. [PubMed] [Google Scholar]

58. Zeber JE, Copeland LA, Good CB, Fine MJ, Bauer MS, Kilbourne AM. Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. J Affect Disord. 2008;107:53–62. [PubMed] [Google Scholar]

59. Bates JA, Whitehead R, Bolge SC, Kim E. Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey. Prim Care Companion J Clin Psychiatry. 2010;12:pii: PCC.09m00883. [PMC free article] [PubMed] [Google Scholar]

60. Fleck DE, Keck PE, Corey KB, Strakowski SM. Factors associated with medication adherence in African American and white patients with bipolar disorder. J Clin Psychiatry. 2005;66:646–652. [PubMed] [Google Scholar]

61. Byrne N, Regan C, Livingston G. Adherence to treatment in mood disorders. Curr Opin Psychiatry. 2006;19:44–49. [PubMed] [Google Scholar]

62. Aagaard J, Vestergaard P, Maarbjerg K. Adherence to lithium prophylaxis: II. Multivariate analysis of clinical, social, and psychosocial predictors of nonadherence. Pharmacopsychiatry. 1988;21:166–170. [PubMed] [Google Scholar]

63. Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70 Suppl 4:1–46; quiz 47-48. [PubMed] [Google Scholar]

64. Yen CF, Chen CS, Ko CH, Yeh ML, Yang SJ, Yen JY, Huang CF, Wu CC. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. Psychiatry Clin Neurosci. 2005;59:403–409. [PubMed] [Google Scholar]

65. Copeland LA, Zeber JE, Salloum IM, Pincus HA, Fine MJ, Kilbourne AM. Treatment adherence and illness insight in veterans with bipolar disorder. J Nerv Ment Dis. 2008;196:16–21. [PubMed] [Google Scholar]

66. Mathew AJ, Samuel B, Jacob KS. Perceptions of illness in self and in others among patients with bipolar disorder. Int J Soc Psychiatry. 2010;56:462–470. [PubMed] [Google Scholar]

67. Maarbjerg K, Aagaard J, Vestergaard P. Adherence to lithium prophylaxis: I. Clinical predictors and patient’s reasons for nonadherence. Pharmacopsychiatry. 1988;21:121–125. [PubMed] [Google Scholar]

68. Perlis RH, Ostacher MJ, Miklowitz DJ, Hay A, Nierenberg AA, Thase ME, Sachs GS. Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study. J Clin Psychiatry. 2010;71:296–303. [PubMed] [Google Scholar]

69. Eker F, Harkın S. Effectiveness of six-week psychoeducation program on adherence of patients with bipolar affective disorder. J Affect Disord. 2012;138:409–416. [PubMed] [Google Scholar]

70. Belzeaux R, Correard N, Boyer L, Etain B, Loftus J, Bellivier F, Bougerol T, Courtet P, Gard S, Kahn JP, et al. Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: results from the FACE-BD cohort. J Affect Disord. 2013;151:1009–1015. [PubMed] [Google Scholar]

71. Bech P, Vendsborg PB, Rafaelsen OJ. Lithium maintenance treatment of manic-melancholic patients: its role in the daily routine. Acta Psychiatr Scand. 1976;53:70–81. [PubMed] [Google Scholar]

72. Jamison KR, Gerner RH, Hammen C, Padesky C. Clouds and silver linings: positive experiences associated with primary affective disorders. Am J Psychiatry. 1980;137:198–202. [PubMed] [Google Scholar]

73. Gitlin MJ, Cochran SD, Jamison KR. Maintenance lithium treatment: side effects and compliance. J Clin Psychiatry. 1989;50:127–131. [PubMed] [Google Scholar]

74. Nilsson A, Axelsson R. Factors associated with discontinuation of long-term lithium treatment. Acta Psychiatr Scand. 1989;80:221–230. [PubMed] [Google Scholar]

75. Morselli PL, Elgie R. GAMIAN-Europe/BEAM survey I--global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders. Bipolar Disord. 2003;5:265–278. [PubMed] [Google Scholar]

76. Scott J. Predicting medication non-adherence in severe affective disorders. Acta Neuropsychiatr. 2000;12:128–130. [PubMed] [Google Scholar]

77. Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry. 2002;159:1927–1929. [PubMed] [Google Scholar]

78. Foster A, Sheehan L, Johns L. Promoting treatment adherence in patients with bipolar disorder. Current Psychiatry. 2011:10: 45–52. [Google Scholar]

79. Sajatovic M, Jenkins JH, Cassidy KA, Muzina DJ. Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder. J Affect Disord. 2009;115:360–366. [PMC free article] [PubMed] [Google Scholar]

80. Savaş HA, UnalA, Vırıt O. Treatment adherence in bipolar disorder. JMOOD. 2011;1:95–102. [Google Scholar]

81. Kriegshauser K, Sajatovic M, Jenkins JH, Cassidy KA, Muzina D, Fattal O, Smith D, Singer B. Gender differences in subjective experience and treatment of bipolar disorder. J Nerv Ment Dis. 2010;198:370–372. [PMC free article] [PubMed] [Google Scholar]

82. Vega P, Alonso M, Alberich S, Barbeito S, de Azúa SR, Ugarte A. Why do bipolar men not comply with treatment? The Spanish CIBERSAM data. Eur J Psychiatr. 2009;23(Suppl):63–69. [Google Scholar]

83. Sajatovic M, Micula-Gondek W, Tatsuoka C, Bialko C. The relationship of gender and gender identity to treatment adherence among individuals with bipolar disorder. Gend Med. 2011;8:261–268. [PMC free article] [PubMed] [Google Scholar]

84. Dharmendra MS, Eagles JM. Factors associated with patients’ knowledge of and attitudes towards treatment with lithium. J Affect Disord. 2003;75:29–33. [PubMed] [Google Scholar]

85. Kleindienst N, Greil W. Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder? J Clin Psychiatry. 2004;65:966–974. [PubMed] [Google Scholar]

86. Kessing LV, Hansen HV, Bech P. Attitudes and beliefs among patients treated with mood stabilizers. Clin Pract Epidemiol Ment Health. 2006;2:8. [PMC free article] [PubMed] [Google Scholar]

87. Teter CJ, Falone AE, Bakaian AM, Tu C, Ongür D, Weiss RD. Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder. Psychiatry Res. 2011;190:253–258. [PMC free article] [PubMed] [Google Scholar]

88. Medina E, Salvà J, Ampudia R, Maurino J, Larumbe J. Short-term clinical stability and lack of insight are associated with a negative attitude towards antipsychotic treatment at discharge in patients with schizophrenia and bipolar disorder. Patient Prefer Adherence. 2012;6:623–629. [PMC free article] [PubMed] [Google Scholar]

89. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331–342. [PubMed] [Google Scholar]

90. Scott J, Tacchi MJ. A pilot study of concordance therapy for individuals with bipolar disorders who are non-adherent with lithium prophylaxis. Bipolar Disord. 2002;4:386–392. [PubMed] [Google Scholar]

91. Cochran SD, Gitlin MJ. Attitudinal correlates of lithium compliance in bipolar affective disorders. J Nerv Ment Dis. 1988;176:457–464. [PubMed] [Google Scholar]

92. Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res. 2008;64:41–46. [PubMed] [Google Scholar]

93. Gadkari AS, McHorney CA. Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res. 2012;12:98. [PMC free article] [PubMed] [Google Scholar]

94. Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–567. [PubMed] [Google Scholar]

95. Even C, Richard H, Thuile J, Friedman S, Rouillon F. Characteristics of voluntary participants versus nonparticipants in a psychoeducation program for euthymic patients with bipolar disorder. J Nerv Ment Dis. 2007;195:262–265. [PubMed] [Google Scholar]

96. Pope M, Scott J. Do clinicians understand why individuals stop taking lithium? J Affect Disord. 2003;74:287–291. [PubMed] [Google Scholar]

97. Mert DG, Turgut NH, Kelleci M, Semiz M. Perspectives on reasons of medication nonadherence in psychiatric patients. Patient Prefer Adherence. 2015;9:87–93. [PMC free article] [PubMed] [Google Scholar]

98. Devulapalli KK, Ignacio RV, Weiden P, Cassidy KA, Williams TD, Safavi R, Blow FC, Sajatovic M. Why do persons with bipolar disorder stop their medication? Psychopharmacol Bull. 2010;43:5–14. [PMC free article] [PubMed] [Google Scholar]

99. Weiss RD, Greenfield SF, Najavits LM, Soto JA, Wyner D, Tohen M, Griffin ML. Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry. 1998;59:172–174. [PubMed] [Google Scholar]

100. Hajda M, Kamaradova D, Latalova K, Prasko J, Ociskova M, Mainerova B. Self-stigma, treatment adherence, and medication discontinuation in patients with bipolar disorders in remission – a cross sectional study. Act Nerv Super Rediviva. 2015;57:6–11. [Google Scholar]

101. Sajatovic M, Levin J, Fuentes-Casiano E, Cassidy KA, Tatsuoka C, Jenkins JH. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication. Compr Psychiatry. 2011;52:280–287. [PMC free article] [PubMed] [Google Scholar]

102. Moon E, Chang JS, Kim MY, Seo MH, Cha B, Ha TH, Choi S, Cho HS, Park T, Ha K. Dropout rate and associated factors in patients with bipolar disorders. J Affect Disord. 2012;141:47–54. [PubMed] [Google Scholar]

103. Darling CA, Olmstead SB, Lund VE, Fairclough JF. Bipolar disorder: medication adherence and life contentment. Arch Psychiatr Nurs. 2008;22:113–126. [PubMed] [Google Scholar]

104. Van Putten T. Why do patients with manic-depressive illness stop their lithium? Compr Psychiatry. 1975;16:179–183. [PubMed] [Google Scholar]

105. Greenhouse WJ, Meyer B, Johnson SL. Coping and medication adherence in bipolar disorder. J Affect Disord. 2000;59:237–241. [PubMed] [Google Scholar]

106. Gibson S, Brand SL, Burt S, Boden ZV, Benson O. Understanding treatment non-adherence in schizophrenia and bipolar disorder: a survey of what service users do and why. BMC Psychiatry. 2013;13:153. [PMC free article] [PubMed] [Google Scholar]

107. Miasso AI, Cassiani SH, Pedrão LJ. [Affective bipolar disorder and ambivalence in relation to the drug treatment: analyzing the causal conditions] Rev Esc Enferm USP. 2011;45:433–441. [PubMed] [Google Scholar]

108. Chang CW, Sajatovic M, Tatsuoka C. Correlates of attitudes towards mood stabilizers in individuals with bipolar disorder. Bipolar Disord. 2015;17:106–112. [PMC free article] [PubMed] [Google Scholar]

109. Soares JJF, Stintzingc CP, Jackson C, Skoldin B. Psychoeducation for patients with bipolar disorder: An exploratory study. Nord J Psychiatry. 2009;51:439–446. [Google Scholar]

110. Barraco A, Rossi A, Nicolò G. Description of study population and analysis of factors influencing adherence in the observational Italian study “Evaluation of Pharmacotherapy Adherence in Bipolar Disorder” (EPHAR) CNS Neurosci Ther. 2012;18:110–118. [PMC free article] [PubMed] [Google Scholar]

111. Hou R, Cleak V, Peveler R. Do treatment and illness beliefs influence adherence to medication in patients with bipolar affective disorder? A preliminary cross-sectional study. Eur Psychiatry. 2010;25:216–219. [PubMed] [Google Scholar]

112. Revicki DA, Hanlon J, Martin S, Gyulai L, Nassir Ghaemi S, Lynch F, Mannix S, Kleinman L. Patient-based utilities for bipolar disorder-related health states. J Affect Disord. 2005;87:203–210. [PubMed] [Google Scholar]

113. Rosa AR, Andreazza AC, Sanchez-Moreno J, Gazalle FK, Santin, A, Stein A. Validation of the Portuguese version of the Lithium Attitudes Questionnaire (LAQ) in bipolar patients treated with lithium: cross-over study. Clin Pract Epidemiol Ment Health. 2006;2:32. [PMC free article] [PubMed] [Google Scholar]

114. Strauss JL, Johnson SL. Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms. Psychiatry Res. 2006;145:215–223. [PMC free article] [PubMed] [Google Scholar]

115. Martin DJ, Garske JP, Davis MK. Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. J Consult Clin Psychol. 2000;68:438–450. [PubMed] [Google Scholar]

116. Mitchell AJ, Selmes T. Why don’t patients take their medicine? Reasons and solutions in psychiatry. Adv Psychiatr Treat. 2007;13:336–346. [Google Scholar]

117. McCabe R, Bullenkamp J, Hansson L, Lauber C, Martinez-Leal R, Rössler W, Salize HJ, Svensson B, Torres-Gonzalez F, van den Brink R, et al. The therapeutic relationship and adherence to antipsychotic medication in schizophrenia. PLoS One. 2012;7:e36080. [PMC free article] [PubMed] [Google Scholar]

118. Lee S, Wing YK, Wong KC. Knowledge and compliance towards lithium therapy among Chinese psychiatric patients in Hong Kong. Aust N Z J Psychiatry. 1992;26:444–449. [PubMed] [Google Scholar]

119. Perron BE, Zeber JE, Kilbourne AM, Bauer MS. A brief measure of perceived clinician support by patients with bipolar spectrum disorders. J Nerv Ment Dis. 2009;197:574–579. [PubMed] [Google Scholar]

120. Sylvia LG, Hay A, Ostacher MJ, Miklowitz DJ, Nierenberg AA, Thase ME, Sachs GS, Deckersbach T, Perlis RH. Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder. J Clin Psychopharmacol. 2013;33:343–350. [PMC free article] [PubMed] [Google Scholar]

121. Frank E, Kupfer DJ, Siegel LR. Alliance not compliance: a philosophy of outpatient care. J Clin Psychiatry. 1995;56 Suppl 1:11–16; discussion 16-17. [PubMed] [Google Scholar]

122. Lewis L. Patient perspectives on the diagnosis, treatment, and management of bipolar disorder. Bipolar Disord. 2005;7(Suppl 1):33–37. [Google Scholar]

123. Cochran SD. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. J Consult Clin Psychol. 1984;52:873–878. [PubMed] [Google Scholar]

124. Connelly CE, Davenport YB, Nurnberger JI. Adherence to treatment regimen in a lithium carbonate clinic. Arch Gen Psychiatry. 1982;39:585–588. [PubMed] [Google Scholar]

125. Gaudiano BA, Miller IW. Patients’ expectancies, the alliance in pharmacotherapy, and treatment outcomes in bipolar disorder. J Consult Clin Psychol. 2006;74:671–676. [PubMed] [Google Scholar]

126. Even C, Thuile J, Kalck-Stern M, Criquillion-Doublet S, Gorwood P, Rouillon F. Psychoeducation for patients with bipolar disorder receiving lithium: short and long term impact on locus of control and knowledge about lithium. J Affect Disord. 2010;123:299–302. [PubMed] [Google Scholar]

127. Delany N. How much do patients on lithium know about their medication? Psychiatric Bulletin. 1991:15: 136–137. [Google Scholar]

128. Bowskill R, Clatworthy J, Parham R, Rank T, Horne R. Patients’ perceptions of information received about medication prescribed for bipolar disorder: implications for informed choice. J Affect Disord. 2007;100:253–257. [PubMed] [Google Scholar]

129. Agyapong VI, Nwankwo V, Bangaru R, Kirrane R. Sources of patients’ knowledge of the adverse effects of psychotropic medication and the perceived influence of adverse effects on compliance among service users attending community mental health services. J Clin Psychopharmacol. 2009;29:565–570. [PubMed] [Google Scholar]

130. Schaub RT, Berghoefer A, Müller-Oerlinghausen B. What do patients in a lithium outpatient clinic know about lithium therapy? J Psychiatry Neurosci. 2001;26:319–324. [PMC free article] [PubMed] [Google Scholar]

131. Harvey NS, Peet M. Lithium maintenance: 2. Effects of personality and attitude on health information acquisition and compliance. Br J Psychiatry. 1991;158:200–204. [PubMed] [Google Scholar]

132. Dogan S, Sabanciogullari S. The effect of patient education in lithium therapy on quality of life and compliance. Arch Psych Nursing. 2003;17:270–275. [PubMed] [Google Scholar]

133. Rosa AR, Andreazza AC, Gazalle FK, Sanchez-Moreno J, Santin, A, Stein A. Adaptation and validation of the Portuguese version of the Lithium Knowledge Test (LKT) of bipolar patients treated with lithium: cross-over study. Clin Pract Epidemiol Ment Health. 2006;2:34. [PMC free article] [PubMed] [Google Scholar]

134. Glover KJ, Lawley D. How safe is lithium prescribing? Audit of a local prescribing framework and patient survey. Psychiatric Bulletin. 2005;29:98–100. [Google Scholar]

135. Cely EEP, Fierro M, Pinilla MI. Prevalence and factors associated with non-adherence in drug maintenance treatment in adults with bipolar affective disorder. Rev Colomb Psiquiatr. 2011;40:85–98. [Google Scholar]

136. Drotar D, Greenley RN, Demeter CA, McNamara NK, Stansbrey RJ, Calabrese JR, Stange J, Vijay P, Findling RL. Adherence to pharmacological treatment for juvenile bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:831–839. [PubMed] [Google Scholar]

137. da Cruz LP, Miranda PM, Vedana KGG, Miasso AI. Medication therapy: adherence, knowledge and difficulties of elderly people from bipolar disorder. Rev Latino-Am Enfermagem. 2011;19:944–952. [PubMed] [Google Scholar]

138. Scott J, Colom F, Pope M, Reinares M, Vieta E. The prognostic role of perceived criticism, medication adherence and family knowledge in bipolar disorders. J Affect Disord. 2012;142:72–76. [PubMed] [Google Scholar]

139. Sajatovic M, Jenkins JH. Is antipsychotic medication stigmatizing for people with mental illness? Int Rev Psychiatry. 2007;19:107–112. [PubMed] [Google Scholar]

140. Kutzelnigg A, Kopeinig M, Chen CK, Fábián A, Pujol-Luna MG, Shin YC, Treuer T, D’yachkova Y, Deix C, Kasper S, et al. Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study. Int J Bipolar Disord. 2014;2:13. [PMC free article] [PubMed] [Google Scholar]

141. Bhugra D, Flick GR. Pathways to care for patients with bipolar disorder. Bipolar Disord. 2005;7:236–245. [PubMed] [Google Scholar]

142. Tibaldi G, Salvador-Carulla L, García-Gutierrez JC. From treatment adherence to advanced shared decision making: new professional strategies and attitudes in mental health care. Curr Clin Pharmacol. 2011;6:91–99. [PubMed] [Google Scholar]